APA (7th ed.) Citation

Levicki, R., Benčić, M. L., Vranešić, I. I., Bradić, L., Begovac, M., Jug, J., & Plavetić, N. D. (2023, February). Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer. The Egyptian Heart Journal.

Chicago Style (17th ed.) Citation

Levicki, Rea, Martina Lovrić Benčić, Irena Ivanac Vranešić, Lada Bradić, Marta Begovac, Juraj Jug, and Natalija Dedić Plavetić. "Effects of Trastuzumab and Trastuzumab Emtansine on Corrected QT Interval and Left Ventricular Ejection Fraction in Patients with Metastatic (HER2+) Breast Cancer." The Egyptian Heart Journal Feb. 2023.

MLA (9th ed.) Citation

Levicki, Rea, et al. "Effects of Trastuzumab and Trastuzumab Emtansine on Corrected QT Interval and Left Ventricular Ejection Fraction in Patients with Metastatic (HER2+) Breast Cancer." The Egyptian Heart Journal, Feb. 2023.

Warning: These citations may not always be 100% accurate.